INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Their core work

ICGEB is an intergovernmental research organization based in Trieste, Italy, operating as a centre of excellence in life sciences and biotechnology. It conducts research spanning immuno-oncology, drug delivery, advanced biomaterials, and genetic engineering, with a strong mandate for international scientific cooperation and capacity building. Within H2020, ICGEB contributed expertise in translational cancer research, responsible research governance, and nanomaterial development for sustainable applications. The centre bridges fundamental bioscience research with practical outcomes in public health and green materials.

What they specialise in

How they've shifted over time

ICGEB's early H2020 involvement (2016-2018) centred on biomedical research — immuno-oncology, cancer translational studies, and HIV cure acceleration, reflecting its core life sciences identity. In the later period (2018-2025), the focus broadened in two directions: institutional transformation (research governance, gender, ethics, open access via STARBIOS 2) and advanced green materials (nanopeptides, bioplastics, green sonochemistry via PEPSA-MATE). This shift suggests the centre is expanding beyond pure biomedical research into sustainability-oriented materials science while also investing in responsible research practices.

ICGEB is moving toward green chemistry and bio-based materials, making them an increasingly relevant partner for sustainable manufacturing and drug delivery projects.

How they like to work

ICGEB participates exclusively as a partner — none of its four H2020 projects were self-coordinated, indicating a preference for contributing specialist expertise to externally led consortia. With 31 unique partners across 20 countries from just 4 projects, they join large, geographically diverse consortia rather than tight-knit repeat teams. This profile suits organizations looking for a globally connected research partner that brings deep bioscience expertise without seeking to lead.

ICGEB has collaborated with 31 unique partners across 20 countries in just 4 projects, reflecting an exceptionally broad international network. This reach aligns with its intergovernmental mandate spanning over 60 member states worldwide.

What sets them apart

ICGEB is not a typical national research centre — it is an intergovernmental organization under the United Nations umbrella with labs in Trieste, New Delhi, and Cape Town, giving it genuine global reach uncommon among EU project participants. Its combination of deep life sciences research with an institutional mandate for international knowledge transfer makes it a distinctive partner for projects requiring both scientific excellence and developing-country engagement. For consortium builders, ICGEB offers a rare bridge between European research networks and the Global South.

Highlights from their portfolio

• PEPSA-MATE
  Represents ICGEB's strategic shift into sustainable nanomaterials — combining peptides, glycogen, and green sonochemistry for bioplastics and drug delivery (running until 2025).
• STREAM
  Largest funded project (EUR 134,544) focused on immuno-oncology excellence, connecting cancer research teams across institutions via MSCA-RISE mobility.
• STARBIOS 2
  Unusual for a hardcore research lab — ICGEB participated in institutional transformation covering gender, ethics, and open access, signalling commitment to responsible research.